Immediate Impact
2 by Nobel laureates 55 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
2025 Standout
Works of Frank Meiß being referenced
miR-146a Controls Immune Response in the Melanoma Microenvironment
2018
Immunotherapy for Malignant Melanoma Robert
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Frank Meiß | 539 | 306 | 165 | 187 | 83 | 1.1k | |
| Libero Ciuffreda | 768 | 288 | 59 | 157 | 62 | 1.3k | |
| Stephen M. Schleicher | 365 | 598 | 102 | 190 | 61 | 1.3k | |
| Xi Yu | 254 | 498 | 85 | 133 | 60 | 1.3k | |
| J.R. Marsden | 526 | 448 | 225 | 379 | 44 | 1.1k | |
| Man‐Hsin Hung | 479 | 529 | 74 | 206 | 45 | 1.3k | |
| Jun Higashijima | 655 | 313 | 59 | 113 | 100 | 1.3k | |
| Wenfeng Tan | 255 | 495 | 36 | 371 | 72 | 1.3k | |
| Polly Niravath | 446 | 190 | 117 | 76 | 52 | 938 | |
| Frederick Lansigan | 338 | 164 | 161 | 282 | 100 | 952 | |
| Yeşim Eralp | 532 | 181 | 46 | 99 | 91 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...